By Lovemore Khomo
A 31 year-old Tendai Chigwada, who’s not her real name, a sex worker from Chinsapo Township, Lilongwe is one of the recipients of injectable cabotegravir (CAB-LA) as pre-exposure prophylaxis (PrEP) for HIV prevention.
Tendai has just switched from oral PrEP to new injectable ones after three years of taking pills since was introduced in 2020.
She narrates that decided to start taking oral PrEP after realizing that was on high risk to get infected with HIV.